Literature DB >> 302211

Accessory cell dependence of lectin-induced proliferation of mouse T lymphocytes.

S Habu, M C Raff.   

Abstract

Mouse lymph node cells were exposed to carbonyl iron and a magnet to remove phagocytic cells, and passed over Sephadex G-10 and nylon wool and incubated for 12 h on plastic to remove adherent cells and their precursors. More than 99% of the cells in this macrophage-depleted population (which constituted 3-5% of the starting population) were Thy-1+ and Ly-1+, while less than 2% were Ly-2+. These cells usually did not synthesize detectable amounts of DNA when cultured with concanavalin A and responded poorly to phytohemagglutinin. These proliferative responses were completely reconstituted by small numbers of syngeneic or allogeneic peritoneal cells, purified peritoneal macrophages or cells from tertiary cultures of mouse embryo 'fibroblasts', but not by 3T3 cells, P815 mastocytoma cells or Nulli SCC-1 embryonal carcinoma cells, or by 2-mercaptoethanol. The reconstituting peritoneal cells were Thy-1--, Ia+ and present in nu/nu mice; although they had to be alive to reconstitute, they did not have to divide. These results are consistent with the hypothesis that T cell proliferation induced by lectins, like that induced by antigens, may involve the dual recognition of stimulating ligand in association with major histocompatibility complex (Ia) determinants.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 302211     DOI: 10.1002/eji.1830070710

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  40 in total

1.  Studies on the accessory requirement for T lymphocyte activation by concanavalin A.

Authors:  R B Gallagher; A Whelan; C Feighery
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

2.  Antigen-dependent and -independent proliferative T-cell populations in the peritoneal exudate cells of immunized mice.

Authors:  T Nitta; K Nemoto; H Yabuta; S Okumura; M Nakano
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

3.  Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells?

Authors:  L Padet; I St-Amour; É Aubin; R Bazin
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

4.  The roles of interleukins in the synergistic effect of B-cell mitogens with concanavalin A on hydrocortisone-resistant thymic cell proliferation.

Authors:  T Nitta; H Konno-Ejiri; K Nemoto; S Okumura; A Ozawa; M Nakano
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

5.  A non-T:non-B cell bears I-A, I-E, I-J, and Tla (Qa-1?) determinants.

Authors:  S Habu; K Yamauchi; R K Gershon; D B Murphy
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Effect of murine cytomegalovirus infection on mitogen responses in genetically resistant and susceptible mice.

Authors:  J E Allan; G R Shellam; J E Grundy
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  Anchorage and lymphocyte function. Contact-induced augmentation of T-cell activation.

Authors:  K G Sundqvist; L Wanger
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

8.  In vivo normobaric oxygen exposure depresses spleen cell in vitro Con A response. Effects of 2-mercaptoethanol and peritoneal cells.

Authors:  M A Gougerot-Pocidalo; M Fay; J J Pocidalo
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

9.  Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice.

Authors:  J A Levy; A B Ibrahim; T Shirai; K Ohta; R Nagasawa; H Yoshida; J Estes; M Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro.

Authors:  E R Ashida; A R Johnson; P E Lipsky
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.